...
首页> 外文期刊>Journal of drugs in dermatology: JDD >Bullous pemphigoid following therapy with an oral beta-blocker.
【24h】

Bullous pemphigoid following therapy with an oral beta-blocker.

机译:用口腔β阻滞剂进行治疗后大疱性斑脂骨。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A causal relationship is thought to exist between several medications and the development of bullous pemphigoid. Commonly implicated medications include furosemide, penicillins, and ibuprofen. The following is a case report of an elderly man who developed generalized bullous pemphigoid for the first time after beginning therapy with an oral beta-blocker. A literature search revealed only 2 other reports of beta-blocker associated bullous pemphigoid. As both bullous pemphigoid and beta-blockers are common in elderly patients, dermatologists may want to consider beta-blockers as potential etiological agents in the development of bullous pemphigoid.
机译:在几种药物和大疱性毒性的发展之间认为存在因果关系。 常用的药物包括呋塞米,青霉素和布洛芬。 以下是一份老年人的案例报告,该老人在开始治疗口服β阻滞后首次开发了广义大疱性动物斑。 文献搜索只显示了另外2个关于Beta-Daller相关的大疱性大疱的Pemphigoid的报告。 随着B11大疱性肺泡和β-阻滞剂在老年患者中常见,皮肤科医生可能希望考虑BETA阻滞剂作为大疱性Pemphigoid的潜在病因制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号